Financials

News Discussions Technicals Forecast Seasonals

COPN fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to COSMO PHARMACEUTICALS NV operating, investing, and financing activities

COPN free cash flow for H1 24 is 97.19 M EUR. For 2023, COPN free cash flow was 27.95 M EUR and operating cash flow was 31.45 M EUR.

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: EUR

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—